Effect of overweight and obesity on cardiovascular events in asymptomatic aortic stenosis: A SEAS substudy (Simvastatin Ezetimibe in Aortic Stenosis)

Journal of the American College of Cardiology

Volumn 62, Issue 18, 2013, Pages 1683-1690

  Rogge, Barbara P ^a   Cramariuc, Dana ^a   Lønnebakken, Mai Tone ^a,b   Gohlke Bärwolf, Christa ^c   Chambers, John B ^d   Boman, Kurt ^e   Gerdts, Eva ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^e UMEÅ UNIVERSITY   (Sweden)

Author keywords

aortic valve stenosis; body mass index; cardiovascular disease; obesity; outcomes

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGE; AGED; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; OBESITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SURVIVAL PREDICTION; TRIACYLGLYCEROL BLOOD LEVEL;

ANALYSIS OF VARIANCE; ANOVA; AORTIC VALVE STENOSIS; AS; BMI; BODY MASS INDEX; CABG; CARDIOVASCULAR; CARDIOVASCULAR DISEASE; CORONARY-ARTERY BYPASS GRAFTING; CV; LEFT VENTRICULAR; LEFT VENTRICULAR EJECTION FRACTION; LV; LVEF; METABOLIC SYNDROME; METS; OBESITY; OUTCOMES; PCI; PERCUTANEOUS CORONARY INTERVENTION;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VENTRICLES; HUMANS; HYPERTENSION; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; OVERWEIGHT; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 84886426447     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.04.081     Document Type: Article

References (39)

1. R.V. Freeman, and C.M. Otto Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies Circulation 111 2005 3316 3326
2. P. Mathieu, J.P. Despres, and P. Pibarot The 'valvulo-metabolic' risk in calcific aortic valve disease Can J Cardiol 23 Suppl B 2007 32B 39B
3. H.B. Hubert, M. Feinleib, P.M. McNamara, and W.P. Castelli Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study Circulation 67 1983 968 977
4. A.E. Rieck, D. Cramariuc, and K. Boman Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events Hypertension 60 2012 90 97
5. B.P. Lund, C. Gohlke-Barwolf, D. Cramariuc, A.B. Rossebo, A.E. Rieck, and E. Gerdts Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy) Am J Cardiol 105 2010 1456 1460
6. G. de Simone, R.B. Devereux, M.J. Roman, M.H. Alderman, and J.H. Laragh Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults Hypertension 23 1994 600 606
7. E. Gerdts, G. de Simone, and B.P. Lund Impact of overweight and obesity on cardiac benefit of antihypertensive treatment Nutr Metab Cardiovasc Dis 2011
8. M. Chinali, G. de Simone, and M.J. Roman Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study J Am Coll Cardiol 47 2006 2267 2273
9. R. Capoulade, M.A. Clavel, and J.G. Dumesnil Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy J Am Coll Cardiol 60 2012 216 223
10. A. Page, J.G. Dumesnil, and M.A. Clavel Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin) J Am Coll Cardiol 55 2010 1867 1874
11. E.E. Calle, M.J. Thun, J.M. Petrelli, C. Rodriguez, and C.W. Heath Jr. Body-mass index and mortality in a prospective cohort of U.S. adults N Engl J Med 341 1999 1097 1105
12. A. Oreopoulos, R. Padwal, C.M. Norris, J.C. Mullen, V. Pretorius, and K. Kalantar-Zadeh Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis Obesity (Silver Spring) 16 2008 442 450
13. C.E. Hastie, S. Padmanabhan, and R. Slack Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention Eur Heart J 31 2010 222 226
14. W.C. Roberts, C.C. Roberts, and T.J. Vowels Effect of body mass index on survival in patients having aortic valve replacement for aortic stenosis with or without concomitant coronary artery bypass grafting Am J Cardiol 108 2011 1767 1771
15. A.B. Rossebo, T.R. Pedersen, and K. Boman Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis N Engl J Med 359 2008 1343 1356
16. S.M. Grundy, J.I. Cleeman, and S.R. Daniels Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752
17. WHO. World Health Organization - Department of Noncommunicable Disease Surveillance: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. WHO/NCD/NCS/99.2. Geneva, 1999. Available at: http://whqlibdoc.who.int/hq/1999/who-ncd-ncs-99.2.pdf. Accessed December 16, 2012.
18. M. Briand, I. Lemieux, and J.G. Dumesnil Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis J Am Coll Cardiol 47 2006 2229 2236
19. A.B. Rossebo, T.R. Pedersen, and C. Allen Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study Am J Cardiol 99 2007 970 973
20. D. Cramariuc, A.E. Rieck, and E.M. Staal Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy) Am J Cardiol 101 2008 510 515
21. D. Cramariuc, G. Cioffi, and A.E. Rieck Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy J Am Coll Cardiol Img 2 2009 390 399
22. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
23. G. de Simone, R. Izzo, and M. Chinali Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? Hypertension 56 2010 99 104
24. E. Gerdts, D. Cramariuc, G. de Simone, K. Wachtell, B. Dahlof, and R.B. Devereux Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study) Eur J Echocardiogr 9 2008 809 815
25. W.H. Gaasch, M.R. Zile, P.K. Hoshino, C.S. Apstein, and A.S. Blaustein Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy Circulation 79 1989 872 883
26. J.N. Bella, V. Palmieri, and M.J. Roman Gender differences in left ventricular systolic function in American Indians (from the Strong Heart Study) Am J Cardiol 98 2006 834 837
27. L.E. Teichholz, T. Kreulen, M.V. Herman, and R. Gorlin Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy Am J Cardiol 37 1976 7 11
28. H. Baumgartner, J. Hung, and J. Bermejo Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice Eur J Echocardiogr 10 2009 1 25
29. E.C. Jones, R.B. Devereux, and M.J. Roman Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study) Am J Cardiol 87 2001 298 304
30. N.E. Lebowitz, J.N. Bella, and M.J. Roman Prevalence and correlates of aortic regurgitation in American Indians: the Strong Heart Study J Am Coll Cardiol 36 2000 461 467
31. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary Am J Clin Nutr 68 1998 899 917
32. M.V. Ngo, J.S. Gottdiener, R.D. Fletcher, D.J. Fernicola, and B.J. Gersh Smoking and obesity are associated with the progression of aortic stenosis Am J Geriatr Cardiol 10 2001 86 90
33. R. Katz, M.J. Budoff, and J. Takasu Relationship of metabolic syndrome with incident aortic valve calcium and aortic valve calcium progression: the Multi-Ethnic Study of Atherosclerosis (MESA) Diabetes 58 2009 813 819
34. T. Lancefield, D.J. Clark, and N. Andrianopoulos Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry J Am Coll Cardiol Intv 3 2010 660 668
35. A. Azimi, M.G. Charlot, and C. Torp-Pedersen Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease Heart 99 2013 655 660
36. M.C. Madala, B.A. Franklin, and A.Y. Chen Obesity and age of first non-ST-segment elevation myocardial infarction J Am Coll Cardiol 52 2008 979 985
37. K.A. Ammar, M.M. Redfield, D.W. Mahoney, M. Johnson, S.J. Jacobsen, and R.J. Rodeheffer Central obesity: association with left ventricular dysfunction and mortality in the community Am Heart J 156 2008 975 981
38. C.Y. Wong, T. O'Moore-Sullivan, R. Leano, N. Byrne, E. Beller, and T.H. Marwick Alterations of left ventricular myocardial characteristics associated with obesity Circulation 110 2004 3081 3087
39. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421